John S Meyer. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » Adrenergic Uptake Inhibitors/therapeutic useAdultAtomoxetine HydrochlorideAttention Deficit Disorder with Hyperactivity/drug therapyAttention Deficit Disorder with Hyperactivity/epidemiologyAttention Deficit Disorder with Hyperactivity/therapyClinical Trials as TopicHumansPropylamines/therapeutic use
Substances: See more » Adrenergic Uptake InhibitorsPropylaminesAtomoxetine Hydrochloride
Year: 2010 PMID: 20070784 PMCID: PMC6493849 DOI: 10.1111/j.1755-5949.2009.00122.x
Source DB: PubMed Journal: CNS Neurosci Ther ISSN: 1755-5930 Impact factor: 5.243